期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

第二代抗精神病药物的有效性 被引量：2

Effectiveness of second generation antipsychotics
下载PDF
导出
摘要 近年来,除氯氮平外的其他第二代抗精神病药被认为是治疗精神病患者的第一线药物,但这些药物未能持续的显示出在疗效方面的优越性。本文从总体结果、精神病症状和副作用三大方面综述国内外相关的研究进展,用于了解第二代抗精神病药物的有效性,进而为抗精神病药的使用提供基础依据。 In recent years, most second generation antipsychotics other than Clozapine are considered first line drugs for a patient suffering from psychosis. But it fails to consistently demonstrate superiority for any of these drugs on effi- cacy measures. This paper summarizes related research progress from global outcomes, symptoms of disease, side ef- fects, with a view to realize effectiveness of second generation antipsychotics, to provide the basis for the use of an- tipsychotics.
作者 张玄 赵幸福 袁国桢 程灶火
机构地区 皖南医学院 江苏省精卫心理研究院江苏省无锡市精神卫生中心
出处 《中国医药导报》 CAS 2013年第21期44-46,共3页 China Medical Herald
基金 江苏省卫生厅医学科研课题(编号H201043)
关键词 第二代抗精神病药 有效性 研究进展 Second generation antipsychotics Effectiveness Research progress
分类号 R749.3 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献20

  • 1American Psychiatric Association. Practice guidelines for the treatment of patients with schizophrenia [J]. Edited by:Arlington VA. American Psychiatric Association : 2004.
  • 2Nasrallah HA,Targum SD,Tandon R,et al. Defining and measuring clinical effectiveness in the treatment of schizophrenia [J]. Psychiat Serv, 2005,56:273-282.
  • 3McEvoy JP,Lieberman JA,Perkins DO ,et al. Efficacy and tol-erabil- ity of olanzapine,quetiapine, and risperidone in the treatment of early psychosis:a randomized,double-blind 52-week comparison [J]. Am J Psychiatry, 2007,164 : 1050-1060.
  • 4McCue RE,Waheed R,Ureuyo L,et al. Comparative effectiveness of second-generation antipsychotics and haloperidol in acute schizophre- nia [J]. Br J Psychiatry ,2006,189:433-440.
  • 5Liebennml JA ,Sttoup'TS,- MeEvoy JP,et al. Effectiveness of tmtipsy- ehotie drugs in patients with chronic schizophrenia [J]. N Engl J Med, 2005,355(12) : 1209-1223.
  • 6Stroup TS,Lieberman JA,McEvoy JP,et al. Effectiveness of Olanzap- ine, quetiapine, and risperidone ion patients with chronic schizophre- nia after discontinuing perphenazine : a catie study [J]. Am J Psychia- try,2007,164:415-427.
  • 7Tunis SL,Faries DE ,Nyhuis AW,et al. Cost-effectiveness of olanzap- ine as first-line treatment for schizophrenia:results from a random- ized ,open-label, 1-year trial [J]. Value Health ,2006,9(2) :77-89.
  • 8刘小玉,杨继章,王学义,金圭星,张一清,宋美,潘康月.利培酮、喹硫平、奥氮平治疗精神分裂症的成本-效果分析[J].中国临床康复,2006,10(10):36-38. 被引量：7
  • 9Swartz MS,Perkins KO, Stroup TS,et al. Effects of antipsychotic med- ications on psychosocial functioning in patients with chronic schizophre- nia:findings from the NIMH CATIE study [J]. Am J Psychiatry,2007, 154:428-436.
  • 10Rosenheck RA,Leslie DL,Sindelar J,et al. Cost-effectiveness of second-generation antipsy-chotics and perphenazine in a random- ized trim of treatment for chronic schizophrenia [J]. Am J Psychiatry, 2006,163:2080-2089.

二级参考文献29

  • 1安国华,季闽春,耿晓芳,程能能.2型糖尿病不同降糖方案的成本-效果分析[J].中国医院药学杂志,2004,24(7):423-424. 被引量：3
  • 2Cutler A J, Kalali AH, Weiden PJ, et al. Four-week, doubleblind, placebo- and ziprasidone-controlled trial of itoperidone in patients with acute exacerbations of schizophrenia [ J ]. J Clin Psychopharmacol, 2008, 28 (2 Suppl 1 ) :S20-28.
  • 3Davidson M, Emsley R, Kramer M, et al. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER) : results of a 6-week, randomized, placebo-controlled study [ J ]. Schizophr Res, 2007, 93 ( 1 ) : 117- 130.
  • 4Kane J, Canas F, Kramer M, et al. Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial [ J ]. Schizophr Res, 2007,90 ( 1 ) : 147-161.
  • 5Keck PE, Orsulak PJ, Cutler A J, etal. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study [J]. J Affect Disord, 2009, 112( 1 ) :36-49.
  • 6Kryzhanovskaya L, Schulz SC, McDougle C, et al. Olanzapine versus placebo in adolescents with schizophrenia: a 6- week, randomized, double-blind, placebo-controlled trial [J]. J Am Acad Child Adolesc Psychiatry, 2009, 48 ( 1 ) : 60 -70.
  • 7Keitner GI, Garlow S J, Ryan CE, et al. A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression[J]. J Psychiatr Res,2009 , 43(3) :205-214.
  • 8Tzimos A, Samokhvalov V, Kramer M, et al. Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebocontrolled study with six-month olden-label extension[ J]. Am J Geriatr Psychiatry,2008,16( 1 ) :31-43.
  • 9McEvoy JP, Daniel DG, Carson WH Jr, et al. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10,15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia [ J ]. J Psychiatr Res, 2007,41 ( 11 ) : 895-905.
  • 10Tohen M, Kryzhanovskaya L, Carlson G, et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania[ J ]. Am J Psychiatry,2007 , 164 (10) : 1547-1556.

共引文献10

同被引文献23

引证文献2

二级引证文献22

中国医药导报
2013年 第21期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部